ADMA Biologics ADMA Increase (Decrease) in Prepaid Expense and Other Assets
Increase (Decrease) in Prepaid Expense and Other Assets at other companies
Other financials
Where this comes from
Reported directly by ADMA Biologics in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets.
The official record: ADMA Biologics’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about ADMA Biologics's increase (decrease) in prepaid expense and other assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is ADMA Biologics's increase (decrease) in prepaid expense and other assets?
- ADMA Biologics (ADMA) reported increase (decrease) in prepaid expense and other assets of $1.6M in Q1 2026.
- How has ADMA Biologics's increase (decrease) in prepaid expense and other assets changed year-over-year?
- ADMA Biologics's increase (decrease) in prepaid expense and other assets decreased by 38.3% year-over-year, from $2.6M to $1.6M.
- What does increase (decrease) in prepaid expense and other assets mean?
- This tracks changes in cash paid in advance for goods or services that will be consumed in future periods. It reflects the timing difference between cash outflows and the recognition of related expenses on the income statement.